title: Adjustable maintenance dosing or total asthma control? Marketing combination inhalers.
authors.affiliation: Rokach Center for the Prevention of Lung Diseases, Clalit Health Services, Jerusalem, Israel. howardl@clalit.org.il
authors.forename: Howard
authors.initials: H
authors.lastname: Liss
mesh_terms: D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage; D019819:Budesonide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004345:Drug Industry; D004983:Ethanolamines / Q000008:administration & dosage; D000068759:Formoterol Fumarate; D006801:Humans; D040541:Marketing; D009330:Nebulizers and Vaporizers
chemical_list: D001993:Bronchodilator Agents; D004338:Drug Combinations; D004983:Ethanolamines; D019819:Budesonide; D000068759:Formoterol Fumarate